On Friday, Allstate Corp (NYSE:ALL)’s shares declined -2.37% to $57.60.
Allstate Insurance Company and the American Football Coaches Association (AFCA) announced today the roster for the 2015 Allstate AFCA Good Works Team®, the most esteemed off-the-field honor in college football. The 22 student-athletes selected for this honor have made a positive impact on others and their communities.
In its 24th year, the Allstate AFCA Good Operates Team® is comprised of athletes who have used their limited free time to perform inspirational acts of service. This summer, the program received an all-time record high 197 nominations from colleges and universities across the country.
College football fans can vote for the 2015 Allstate AFCA Good Operates Team® Captain at ESPN.com/Allstate through November 25, 2015. The Team Captain and his fellow award recipients will be invited to New Orleans to take part in a community project before the 2016 Allstate® Sugar Bowl®.
The Allstate Corporation, through its auxiliaries, engages in the property-liability insurance and life insurance businesses in the United States and Canada. The company’s Allstate Protection segment sells private passenger auto and homeowners insurance products under the Allstate, Encompass, Esurance brand names.
Enterprise Products Partners L.P. (NYSE:EPD)’s shares dropped -1.76% to $26.82.
Enterprise Products Partners L.P. (EPD) declared that its operating partner, Enterprise Products Operating LLC (“EPO”), raised its bank credit facilities by $500 million to provide the company with up to $5.5 billion of aggregate borrowing capacity. The facilities comprise of an amended $4.0 billion multi-year revolving credit agreement that matures in September 2020 and a new $1.5 billion 364-day revolving credit agreement, both of which are unconditionally guaranteed by Enterprise on an unsecured and unsubordinated basis. As of recently, aggregate accessible borrowing capacity under the raised bank credit facilities is about $4.7 billion.
Enterprise Products Partners L.P. is one of the largest publicly traded partnerships and a leading North American provider of midstream energy services to producers and consumers of natural gas, NGLs, crude oil, refined products and petrochemicals. Our services comprise: natural gas gathering, treating, processing, transportation and storage; NGL transportation, fractionation, storage and import and export terminals; crude oil gathering, transportation, storage and terminals; petrochemical and refined products transportation, storage and terminals; petrochemical transportation and services; and a marine transportation business that operates primarily on the United States inland and Intracoastal Waterway systems and in the Gulf of Mexico. The partnership’s assets comprise about 49,000 miles of pipelines; 225 million barrels of storage capacity for NGLs, petrochemicals, refined products and crude oil; and 14 billion cubic feet of natural gas storage capacity.
Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products in the United States and internationally. Its NGL Pipelines & Services segment provides natural gas processing and related NGL marketing services, in addition to import and export terminal services. This segment operates NGL pipelines aggregating about 19,400 miles; NGL and related product storage facilities; and 15 NGL fractionators. The companys Onshore Natural Gas Pipelines & Services segment operates about 19,300 miles of onshore natural gas pipeline systems to gather and transport natural gas in Colorado, Louisiana, New Mexico, Texas, and Wyoming.
At the end of Friday’s trade, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)‘s shares dipped -2.08% to $7.99.
ARIAD Pharmaceuticals, Inc. (ARIA) declared that the first patient has been treated in its OPTIC (Optimizing Ponatinib Treatment In CML) trial of Iclusig® (ponatinib). This randomized, dose-ranging trial is designed to evaluate three starting doses of ponatinib in patients with refractory, chronic-phase chronic myeloid leukemia (CP-CML) and is predictable to inform the optimal use of Iclusig in these patients. About 450 patients will be enrolled at clinical sites around the world.
Major Design Features of the Trial
This study will enroll patients with CP-CML who are resistant to at least two approved TKIs. These patients will be randomized equally to receive once-daily administration of 45 mg (cohort A), 30 mg (cohort B) or 15 mg (cohort C) of ponatinib. Patients in cohorts A and B will have their daily dose reduced to 15 mg upon achievement of major cytogenetic response (MCyR).
The primary endpoint of the trial is MCyR by 12 months for each cohort. Secondary endpoints comprise rate of vascular occlusive events in each dose cohort, rates of adverse events and rates of serious adverse events. Other secondary endpoints comprise cytogenetic, molecular and hematologic response rates, tolerability, duration of response, time to response, disease control rate, progression-free survival and overall survival. Preliminary data from the OPTIC trial is predictable at the end of 2016.
ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult patients with chronic myeloid leukemia (CML), and Philadelphia chromosome-positive acute lymphoblastic leukemia in the United States, Europe, and other territories.
Baker Hughes Incorporated (NYSE:BHI), ended its Friday’s trading session with -3.42% loss, and closed at $53.40.
Baker Hughes Incorporated (BHI) declared that the international rig count for August 2015 was 1,137, up 19 from the 1,118 counted in July 2015, and down 202 from the 1,339 counted in August 2014. The international offshore rig count for August 2015 was 270, up 6 from the 264 counted in July 2015, and down 45 from the 315 counted in August 2014.
The average U.S. rig count for August 2015 was 883, up 17 from the 866 counted in July 2015, and down 1,021 from the 1,904 counted in August 2014. The average Canadian rig count for August 2015 was 206, up 23 from the 183 counted in July 2015, and down 193 from the 399 counted in August 2014.
The worldwide rig count for August 2015 was 2,226, up 59 from the 2,167 counted in July 2015, and down 1,416 from the 3,642 counted in August 2014.
Baker Hughes Incorporated supplies oilfield services, products, technology, and systems to the oil and natural gas industry worldwide. The company offers drilling and evaluation products and services, which comprise drill bits for performance drilling, hole enlargement, and coring; conventional and rotary steerable systems used to drill wells; measurement-while-drilling and logging-while-drilling systems to perform reservoir navigation services; drilling optimization services; tools for coil tubing drilling and wellbore re-entry systems; coring drilling systems; surface logging; emulsion and water-based drilling fluids systems; reservoir drill-in fluids; and fluids environmental services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
